2018
DOI: 10.5935/0004-2749.20180022
| View full text |Cite
|
Sign up to set email alerts
|

Abstract: The results suggest moxifloxacin is a safe option for intracameral use after cataract surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Moxifloxacin hydrochloride (MOX) is often the drug of choice, as it has been shown to have higher intraocular bioavailability compared to other fluoroquinolones 3,20 . However, overall limitations in drug absorption with eye drops mean that prophylactic antibiotic drops still must be used three times or more per day 21,22 …”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Moxifloxacin hydrochloride (MOX) is often the drug of choice, as it has been shown to have higher intraocular bioavailability compared to other fluoroquinolones 3,20 . However, overall limitations in drug absorption with eye drops mean that prophylactic antibiotic drops still must be used three times or more per day 21,22 …”
Section: Introductionmentioning
confidence: 99%
“… 3 , 20 However, overall limitations in drug absorption with eye drops mean that prophylactic antibiotic drops still must be used three times or more per day. 21 , 22…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2007, a major clinical study by the European Society of Cataract and Refractive Surgeons (ESCRS) (3) demonstrated the benefits of intracameral cefuroxime. Recently, three Brazilian studies have demonstrated the safety and efficacy of intracameral moxifloxacin (4)(5)(6) . Nevertheless, the adoption of such scientifically-proven strategies in clinical practice is hindered by other factors.…”
mentioning
confidence: 99%